Amy Johnson

Amy Johnson has a diverse and impressive work experience. Amy is currently working as a Scientist I at Voyager Therapeutics, Inc. since 2022. Prior to this role, Amy was a Postdoctoral Scholar at Vanderbilt University from 2018 to 2022, where they worked on various projects related to the effects of the estrous cycle on cocaine self-administration and sex differences in protein expression. Amy has published three first author papers and has been invited to three international conferences for their work. Amy's skills include in vivo rodent IV drug self-administration, calcium and dopamine imaging, optogenetics, and ex vivo slice voltammetry.

From 2013 to 2017, Amy worked as a Graduate Student at Virginia Commonwealth University, where they focused on developing a preclinical to human laboratory testing pipeline for potential pharmacotherapies for cocaine use disorder. Amy designed experiments to test the mechanism of an effective pharmacotherapy and published two first author papers. Amy was also invited to give presentations at three international conferences based on their work.

Earlier in their career, Amy gained research experience as an Undergraduate Researcher at the University of Wisconsin-Eau Claire from 2011 to 2013. Amy conducted discrimination procedures in rats and set up a new learning and memory procedure in the laboratory. Amy also took on a leadership role overseeing students and experiments.

Overall, Amy Johnson has a strong background in neuroscience research, particularly in the field of addiction, and has made significant contributions through publications and presentations at international conferences. Amy possesses a wide range of skills in laboratory techniques and is currently pursuing their career as a Scientist at Voyager Therapeutics, Inc.

Amy Johnson received their Bachelor of Science (BS) degree in Psychology from the University of Wisconsin-Eau Claire in 2013. Following that, they pursued a Doctor of Philosophy (PhD) degree in Pharmacology and Toxicology from Virginia Commonwealth University, completing it in 2017.